The cholecystokinin antagonist proglumide has an analgesic effect in chronic pancreatitis

Pancreas

Volumn 21, Issue 3, 2000, Pages 324-325

  McCleane, G J ^a  

^a CRAIGAVON AREA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; PHENTOLAMINE; PROGLUMIDE;

ABDOMINAL PAIN; ADULT; ANALGESIA; ARTICLE; CASE REPORT; CHOLECYSTOKININ BLOOD LEVEL; CHRONIC PANCREATITIS; DRUG EFFECT; HUMAN; MALE; PANCREAS FUNCTION; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

ADULT; ANALGESIA; CASE REPORT; CHOLECYSTOKININ; CHRONIC DISEASE; HUMAN; MALE; PANCREAS; PANCREATITIS; PROGLUMIDE;

EID: 0033798641     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200010000-00016     Document Type: Article

References (21)

1. Pharmacological characterization of morphine-induced in vivo release of cholecystokinin in rat dorsal horn effects of ion channel blockers
2. Distinct cholecystokinin receptors in brain and pancreas
3. Opioid and anti-opioid peptides
4. Modulation of opioid antinociception by CCK at the supra spinal level: Evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain
5. Neurobiology of cholecystokinin
6. Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat
7. The role of cholecystokinin in nociception, neuropathic pain and opiate tolerance
8. Prevention of tolerance to the antinociceptive effects of systemic morphine by a selective cholecystokinin-B receptor antagonist in a rat model of peripheral neuropathy
9. Proglumide and benzotript: Members of a different class of cholecystokinin receptor antagonists
10. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat
11. Proglumide prevents and curtails acute tolerance to morphine in rats
12. Proglumide selectively potentiates supraspinal mu 1 opioid analgesia in mice
13. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide
14. Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist
15. The cholecystokinin antagonist proglumide enhances the analgesic efficacy of morphine in humans with chronic benign pain
16. Proglumide exhibits delta opioid agonist properties
17. Plasma cholecystokinin concentrations in patients with advanced chronic pancreatitis
18. Plasma CCK levels in patients with pancreatic insufficiency
19. Gallbladder dynamics in chronic pancreatitis: Relationship to exocrine pancreatic function, CCK and PP release
20. Relationship of basal and postprandial intra duodenal bile acid concentrations and plasma cholecystokinin levels with abdominal pain in patients with chronic pancreatitis
21. Basal and postprandial cholecystokinin values in chronic pancreatitis with and without abdominal pain